Markets
Nvidia CEO Jensen Huang Speaks At The Bipartisan Policy Center
Nvidia cofounder and CEO Jensen Huang speaks about the future of artificial intelligence and its effect on energy consumption and production (Chip Somodevilla/Getty Images)
Biz-AI-Rro World

As earnings loom, Nvidia’s setup is the mirror image of last quarter’s face-ripping gains

Nvidia was on a tear and trouncing its peers ahead of its last earnings report. It’s the opposite case this time around.

Luke Kawa
2/25/25 3:02PM

Just three months have passed since Nvidia last reported earnings, but that might as well have been an alternate universe.

The chip designer ripped higher ahead of its earnings report in November, gaining 25% in the two months prior and far outperforming the VanEck Semiconductor ETF in the process.

This time, the stock is slouching into Wednesday’s release, having suffering a record one-day loss of market cap in January and lagging the semiconductor ETF since late December.

The fundamental backdrop hasn’t changed too much over the course of three months. But the vibes, as the kids say, have shifted. Notwithstanding megacap tech companies’ commitment to spend some $315 billion on capex this year to bolster their AI capabilities, investors are seemingly looking through the current year and wondering when this supercharged spending binge will materially inflect lower. The emergence of DeepSeek and worries that Microsoft may be fully stocked on data centers — a development which is not necessarily germane when it comes to the outlook for GPU demand — have caused some fraying of the everything-AI-to-the-moon thesis.

It’s tough to get much multiple expansion when Nvidia’s earnings and revenue growth rates have come off the boil, but by the same token, it’s tough to get too much multiple contraction when its top and bottom lines are still growing faster than most companies out there.

In the run-up to the November release, we warned of the risk that gains were being pulled forward, meaning that another solid earnings report was likely well embedded in the price. That’s pretty much what came to pass afterward, even as the chip designer delivered higher-than-expected revenues and profits with a better outlook for its fourth quarter than the Street had anticipated.

Is this setup just last quarter’s in reverse? Well, as someone who is on the record vociferously objecting to low-n analysis of this sort, it would be pretty silly to have too much confidence in that view. But the simple logic holds that if you were to report the same set of numbers after going down 10% or up 25%, the reaction would probably be better in the former case than the latter.

“The market is heavily skewed negative right now around tech sentiment with any whisper of worries/concern from DeepSeek to MSFT CapEx causing a brutal ripple impact across the tech ecosystem,” Wedbush analyst Dan Ives wrote. “We expect another robust performance and ‘clear beat and raise special’ from Nvidia that should calm the nerves of investors as Jensen lays out the massive demand drivers from Blackwell and AI Capex in the field fueling this 4th Industrial Revolution.”

More Markets

See all Markets
markets
Luke Kawa
9/5/25

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.